We are live on ! Find out more
APC

Aspire Private Capital Portfolio holdings

AUM $484M
1-Year Est. Return 17.28%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+17.28%
3 Year Est. Return
+49.56%
5 Year Est. Return
+43.58%
10 Year Est. Return
AUM
$314M
AUM Growth
+$13M
Cap. Flow
+$4.38M
Cap. Flow %
1.4%
Top 10 Hldgs %
46.34%
Holding
692
New
35
Increased
163
Reduced
123
Closed
16
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACES icon
626
ALPS Clean Energy ETF
ACES
$120M
$316 ﹤0.01%
+7
New +$306
ADNT icon
627
Adient
ADNT
$1.65B
$307 ﹤0.01%
8
STXS icon
628
Stereotaxis
STXS
$133M
$306 ﹤0.01%
200
LEXX icon
629
Lexaria Bioscience
LEXX
$7.85M
$292 ﹤0.01%
27
EUO icon
630
ProShares UltraShort Euro
EUO
$34.8M
$291 ﹤0.01%
+10
New +$290
ON icon
631
ON Semiconductor
ON
$31.3B
$284 ﹤0.01%
3
CPRX
632
DELISTED
Catalyst Pharmaceutical
CPRX
$269 ﹤0.01%
20
VIVO
633
VivoPower PLC
VIVO
$115M
$266 ﹤0.01%
40
SDC
634
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$265 ﹤0.01%
500
DNOW icon
635
DNOW Inc
DNOW
$2.6B
$259 ﹤0.01%
25
OPAD icon
636
Offerpad Solutions
OPAD
$17.3M
$259 ﹤0.01%
2
TGLS icon
637
Tecnoglass Holdings Inc.
TGLS
$2.07B
$258 ﹤0.01%
5
YOLO icon
638
AdvisorShares Pure Cannabis ETF
YOLO
$29.5M
$257 ﹤0.01%
100
GSK icon
639
GSK
GSK
$103B
$249 ﹤0.01%
7
HYMC icon
640
Hycroft Mining Holding Corp
HYMC
$1.92B
$236 ﹤0.01%
80
ESGV icon
641
Vanguard ESG US Stock ETF
ESGV
$13.3B
$235 ﹤0.01%
+3
New +$221
LUMN icon
642
Lumen
LUMN
$6.65B
$235 ﹤0.01%
104
SCNI
643
Scinai Immunotherapeutics
SCNI
$1.41M
$226 ﹤0.01%
16
BTTX
644
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$216 ﹤0.01%
200
VYM icon
645
Vanguard High Dividend Yield ETF
VYM
$81.4B
$212 ﹤0.01%
+2
New +$210
IVVD icon
646
Invivyd
IVVD
$163M
$210 ﹤0.01%
200
NTZ
647
Natuzzi
NTZ
$14.2M
$210 ﹤0.01%
30
FRLN
648
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$206 ﹤0.01%
80
GTX icon
649
Garrett Motion
GTX
$5.71B
$182 ﹤0.01%
24
PRE icon
650
Prenetics Global
PRE
$315M
$178 ﹤0.01%
13

Similar funds

Aspire Private Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Aspire Private Capital held 692 positions worth $314M, up 4.3% from $301M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Aspire Private Capital's Q2 2023 filing shows 35 new, 163 increased, 123 reduced and 16 closed positions. Its largest new stake was Dell: 14,035 shares worth $759K. The largest sale was State Street SPDR Portfolio Developed World ex-US ETF, an estimated $5.19M.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 4.7% a quarter earlier, followed by Industrials and Healthcare.

  • Aspire Private Capital's largest Q2 2023 buy was Dell: 14,035 shares worth $759K.
  • Aspire Private Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $6.13M increase.
  • Aspire Private Capital's biggest Q2 2023 reduction was State Street SPDR Portfolio Developed World ex-US ETF, cutting an estimated $5.19M.
  • Aspire Private Capital fully exited Wolfspeed in Q2 2023, selling an estimated $52K.
  • Aspire Private Capital's ten largest holdings make up 46% of its $314M portfolio in Q2 2023.
  • Aspire Private Capital opened 35 new positions and closed 16 in Q2 2023.
  • Aspire Private Capital's portfolio value rose 4.3% quarter-over-quarter to $314M.

Based on Aspire Private Capital's 13F filing for Q2 2023, filed 24 Jul 2023.